Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.

Alimentary pharmacology & therapeutics - 1 Apr 2005

Roblin X, Serre-Debeauvais F, Phelip J-M, Faucheron J-L, Hardy G, Chartier A, Helluwaert F, Bessard G, Bonaz B

Abstract excerpt

BACKGROUND: 6-Thioguanine (6-tioguanine) nucleotides are the active metabolites of azathioprine. AIM: The aim of the study was to evaluate the rate of clinical remission without steroids in steroid-dependent Crohn's disease and ulcerative colitis patients receiving azathioprine, the medium- and l...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Azathioprine
Share to Colitis, Ulcerative

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Crohn Disease

Share to Follow-Up Studies

Share to Immunosuppressive Agents

Share to Mercaptopurine

Share to Treatment Outcome

Source

Identifiers

PMID: 15801918
DOI: 10.1111/j.1365-2036.2005.02419.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-15801918-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.PMID 15801918Read ↗

A prospective, open-label trial of 6-thioguanine in patients with ulcerative or indeterminate colitis.Semantic proximity Read ↗

Remission maintenance by tioguanine in chronic active Crohn's disease.Semantic proximity Read ↗

Monitoring 6-thioguanine nucleotide concentrations in Japanese patients with inflammatory bowel disease.Semantic proximity Read ↗

Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendations.Semantic proximity Read ↗

On therapeutic drug monitoring of thiopurines in inflammatory bowel disease; pharmacology, pharmacogenomics, drug intolerance and clinical relevance.Semantic proximity Read ↗

Relationship Between Thiopurine S-Methyltransferase Genotype/Phenotype and 6-Thioguanine Nucleotide Levels in 316 Patients With Inflammatory Bowel Disease on 6-Thioguanine.Semantic proximity Read ↗

Pharmacological monitoring of azathioprine therapy.Semantic proximity Read ↗

Effective long-term solution to therapeutic remission in Inflammatory Bowel Disease: Role of Azathioprine.Semantic proximity Read ↗

Azathioprine and 6‐mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel diseaseSemantic proximity Read ↗

Usefulness of thiopurine methyltransferase and thiopurine metabolite analysis in clinical practice in patients with inflammatory bowel diseases.Semantic proximity Read ↗

Revisiting the Role of Thiopurines in Inflammatory Bowel Disease Through Pharmacogenomics and Use of Novel Methods for Therapeutic Drug MonitoringSemantic proximity Read ↗

Thiopurine Drugs in the Treatment of Ulcerative Colitis: Identification of a Novel Deleterious Mutation in TPMT.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.